Literature DB >> 11478967

Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities.

C E Núñez1, Y Angulo, B Lomonte.   

Abstract

Group II phospholipase A(2) (PLA(2)) myotoxins found in the venoms of Crotalidae snakes can be divided into 'Asp49' and 'Lys49' isoforms, the latter being considered catalytically-inactive variants. Previous studies on one Lys49 isoform, myotoxin II from Bothrops asper, indicated that its myotoxic activity is due to the presence of a short cationic/hydrophobic sequence (115-129) near its C-terminus, which displays membrane-damaging properties. Since the C-terminal region of different group II PLA(2) myotoxins presents considerable sequence variability, synthetic peptides homologous to region 115-129 of myotoxin II, but corresponding to B. asper myotoxin III (Asp49), Agkistrodon piscivorus piscivorus Asp49 PLA(2) and Lys49 PLA(2), were studied to determine the possible functional relevance of such region for the toxic activities of these proteins. Results showed that both Lys49-derived peptides (p-BaK49 and p-AppK49) were able to lyse skeletal muscle C2C12 cells in culture, and to induce edema in the mouse footpad assay. Moreover, p-AppK49, which showed a markedly stronger cytotoxic potency than p-BaK49, additionally induced skeletal muscle necrosis when injected into mice. These observations unequivocally identify the sequence 115-129 (KKYKAYFKLKCKK) of the Lys49 PLA(2) of A. p. piscivorus as containing the key structural determinants needed for myotoxicity, and represent the first report of an unmodified, PLA(2)-derived short synthetic peptide with the ability to reproduce this effect of a parent toxin in vivo. On the other hand, the two Asp49-derived peptides did not show any toxic effects in vitro or in vivo, even at high concentrations. These findings suggests that Lys49 and Asp49 group II PLA(2)s might exert their myotoxic actions through different molecular mechanisms, by implying that the latter may not utilize their C-terminal regions as main membrane-destabilizing elements.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478967     DOI: 10.1016/s0041-0101(01)00141-6

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  21 in total

1.  Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.

Authors:  Xingding Zhou; Tien-Chye Tan; S Valiyaveettil; Mei Lin Go; R Manjunatha Kini; Adrian Velazquez-Campoy; J Sivaraman
Journal:  Biophys J       Date:  2008-06-27       Impact factor: 4.033

2.  Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa.

Authors:  Steven D Aird; Nelson Jorge da Silva; Lijun Qiu; Alejandro Villar-Briones; Vera Aparecida Saddi; Mariana Pires de Campos Telles; Miguel L Grau; Alexander S Mikheyev
Journal:  Toxins (Basel)       Date:  2017-06-08       Impact factor: 4.546

3.  Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity.

Authors:  Morgane Rouault; Lachlan D Rash; Pierre Escoubas; Eric Boilard; James Bollinger; Bruno Lomonte; Thomas Maurin; Carole Guillaume; Stéphane Canaan; Christiane Deregnaucourt; Joseph Schrével; Alain Doglio; José María Gutiérrez; Michel Lazdunski; Michael H Gelb; Gérard Lambeau
Journal:  Biochemistry       Date:  2006-05-09       Impact factor: 3.162

4.  Crystallization and preliminary X-ray crystallographic studies of a Lys49-phospholipase A2 homologue from Bothrops pirajai venom complexed with rosmarinic acid.

Authors:  Juliana I dos Santos; Norival A Santos-Filho; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-05-27

5.  Pharmacological study of edema and myonecrosis in mice induced by venom of the bushmaster snake (Lachesis muta muta) and its basic Asp49 phospholipase A(2) (LmTX-I).

Authors:  Daniela C S Damico; Maria Alice da Cruz Höfling; Mariana Cintra; Marta B Leonardo; Andrana K Calgarotto; Saulo L da Silva; Sérgio Marangoni
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

6.  Interisland mutation of a novel phospholipase A2 from Trimeresurus flavoviridis venom and evolution of Crotalinae group II phospholipases A2.

Authors:  Takahito Chijiwa; Sachiko Hamai; Shoji Tsubouchi; Tomohisa Ogawa; Masanobu Deshimaru; Naoko Oda-Ueda; Shosaku Hattori; Hiroshi Kihara; Susumu Tsunasawa; Motonori Ohno
Journal:  J Mol Evol       Date:  2003-11       Impact factor: 2.395

7.  Distinct sites for myotoxic and membrane-damaging activities in the C-terminal region of a Lys49-phospholipase A2.

Authors:  Lucimara Chioato; Arthur H C De Oliveira; Roberto Ruller; Juliana M Sá; Richard J Ward
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

8.  Crystallization and preliminary X-ray diffraction analysis of a novel Arg49 phospholipase A2 homologue from Zhaoermia mangshanensis venom.

Authors:  Mário T Murakami; Ulrich Kuch; Dietrich Mebs; Raghuvir K Arni
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-06-22

9.  Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLA₂ inhibition.

Authors:  Juliana I Dos Santos; Fábio F Cardoso; Andreimar M Soares; Maeli Dal Pai Silva; Márcia Gallacci; Marcos R M Fontes
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

10.  Structural and phylogenetic studies with MjTX-I reveal a multi-oligomeric toxin--a novel feature in Lys49-PLA2s protein class.

Authors:  Guilherme H M Salvador; Carlos A H Fernandes; Angelo J Magro; Daniela P Marchi-Salvador; Walter L G Cavalcante; Roberto M Fernandez; Márcia Gallacci; Andreimar M Soares; Cristiano L P Oliveira; Marcos R M Fontes
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.